Product Details for NDA 019308
POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE)
5GM/100ML;75MG/100ML;900MG/100ML
Marketing Status: Prescription
5GM/100ML;150MG/100ML;900MG/100ML
Marketing Status: Prescription
5GM/100ML;150MG/100ML;900MG/100ML
Marketing Status: Prescription
5GM/100ML;300MG/100ML;900MG/100ML
Marketing Status: Prescription
5GM/100ML;224MG/100ML;900MG/100ML
Marketing Status: Prescription
5GM/100ML;300MG/100ML;900MG/100ML
Marketing Status: Prescription
5GM/100ML;150MG/100ML;900MG/100ML
Marketing Status: Prescription
5GM/100ML;75MG/100ML;900MG/100ML
Marketing Status: Prescription
Active Ingredient: DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE
Proprietary Name: POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 5GM/100ML;75MG/100ML;900MG/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N019308
Product Number: 004
Approval Date: Apr 5, 1985
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status: Prescription
Patent and Exclusivity Information
POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE)
Proprietary Name: POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 5GM/100ML;75MG/100ML;900MG/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N019308
Product Number: 004
Approval Date: Apr 5, 1985
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status: Prescription
Patent and Exclusivity Information
5GM/100ML;150MG/100ML;900MG/100ML
Marketing Status: Prescription
Active Ingredient: DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE
Proprietary Name: POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 5GM/100ML;150MG/100ML;900MG/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N019308
Product Number: 002
Approval Date: Apr 5, 1985
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status: Prescription
Patent and Exclusivity Information
POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE)
Proprietary Name: POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 5GM/100ML;150MG/100ML;900MG/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N019308
Product Number: 002
Approval Date: Apr 5, 1985
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status: Prescription
Patent and Exclusivity Information
5GM/100ML;150MG/100ML;900MG/100ML
Marketing Status: Prescription
Active Ingredient: DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE
Proprietary Name: POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 5GM/100ML;150MG/100ML;900MG/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: N019308
Product Number: 005
Approval Date: Apr 5, 1985
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status: Prescription
Patent and Exclusivity Information
POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE)
Proprietary Name: POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 5GM/100ML;150MG/100ML;900MG/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: N019308
Product Number: 005
Approval Date: Apr 5, 1985
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status: Prescription
Patent and Exclusivity Information
5GM/100ML;300MG/100ML;900MG/100ML
Marketing Status: Prescription
Active Ingredient: DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE
Proprietary Name: POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 5GM/100ML;300MG/100ML;900MG/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N019308
Product Number: 003
Approval Date: Apr 5, 1985
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status: Prescription
Patent and Exclusivity Information
POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE)
Proprietary Name: POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 5GM/100ML;300MG/100ML;900MG/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N019308
Product Number: 003
Approval Date: Apr 5, 1985
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status: Prescription
Patent and Exclusivity Information
5GM/100ML;224MG/100ML;900MG/100ML
Marketing Status: Prescription
Active Ingredient: DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE
Proprietary Name: POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 5GM/100ML;224MG/100ML;900MG/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N019308
Product Number: 006
Approval Date: Apr 5, 1985
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status: Prescription
Patent and Exclusivity Information
POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE)
Proprietary Name: POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 5GM/100ML;224MG/100ML;900MG/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N019308
Product Number: 006
Approval Date: Apr 5, 1985
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status: Prescription
Patent and Exclusivity Information
5GM/100ML;300MG/100ML;900MG/100ML
Marketing Status: Prescription
Active Ingredient: DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE
Proprietary Name: POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 5GM/100ML;300MG/100ML;900MG/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: N019308
Product Number: 007
Approval Date: Apr 5, 1985
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status: Prescription
Patent and Exclusivity Information
POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE)
Proprietary Name: POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 5GM/100ML;300MG/100ML;900MG/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: N019308
Product Number: 007
Approval Date: Apr 5, 1985
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status: Prescription
Patent and Exclusivity Information
5GM/100ML;150MG/100ML;900MG/100ML
Marketing Status: Prescription
Active Ingredient: DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE
Proprietary Name: POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 5GM/100ML;150MG/100ML;900MG/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N019308
Product Number: 001
Approval Date: Apr 5, 1985
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status: Prescription
Patent and Exclusivity Information
Proprietary Name: POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 5GM/100ML;150MG/100ML;900MG/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N019308
Product Number: 001
Approval Date: Apr 5, 1985
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status: Prescription
Patent and Exclusivity Information